Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.44 |
| ▸ | ADH1C | P00326 | 1/20 | 0.44 |
| ▸ | ADH1A | P07327 | 1/20 | 0.44 |
| ▸ | ADH4 | P08319 | 1/20 | 0.44 |
| ▸ | ADH7 | P40394 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.38 |
| ▸ | GAPDH | P04406 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18998303 | 0.98 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL270377 | 0.93 | TSHR (0.41) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL270914 | 0.84 | — | — | |
| SCHEMBL23188220 | 0.81 | GSR (0.33) | — | |
| SCHEMBL277272 | 0.80 | TSHR (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL14213344 | 0.78 | ADH1C (0.44) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL314509 | 0.78 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL276686 | 0.78 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL28009314 | 0.78 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL19494120 | 0.76 | ADH1C (0.39) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4746242-B2 | — | — | 2011-08-10 | — | — | JP | claimed |
| JP-4681192-B2 | — | — | 2011-05-11 | — | — | JP | claimed |
| EP-1250305-B1 | WASTE WATER TREATMENT IN A METHOD FOR PRODUCING FORMIC ACID WHICH IS FREE OF WATER | BASF SE (DE) | 2009-08-12 | — | — | EP | claimed |
| EP-1250307-B1 | UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID | BASF SE (DE) | 2008-05-21 | — | — | EP | claimed |
| CN-100345813-C | Apparatus and method for preparing anhydrous formic acid | BASF AG (DE) | 2007-10-31 | — | — | CN | claimed |
| US-7241365-B2 | Material for a facility for the production of anhydrous formic acid | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-10 | — | — | US | claimed |
| CN-1271033-C | Utilization of extracting agent as antifoaming agent in production of anhydrous formic acid | BASF AG (DE) | 2006-08-23 | — | — | CN | claimed |
| CN-1271034-C | Wastewater treatment in a process for the preparation of anhydrous formic acid | BASF AG (DE) | 2006-08-23 | — | — | CN | claimed |
| EP-1254099-B1 | PROCESS FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID | BASF AG (DE) | 2006-04-26 | — | — | EP | claimed |
| EP-1250306-B1 | METHOD FOR CLEANING OFF-GAS FLOWS | BASF AG (DE) | 2005-11-09 | — | — | EP | claimed |
| CN-1395553-A | Use of an extraction agent as a defoamer in the preparation of anhydrous formic acid | BASF AG (DE) | 2003-02-05 | — | — | CN | claimed |
| US-20030009057-A1 | Utilization of an extracting agent as antifoaming agent in the production of anhydrous formic acid | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-09 | — | — | US | claimed |
| EP-1254099-A2 | PROCESS FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-06 | — | — | EP | claimed |
| EP-1250306-A2 | METHOD FOR CLEANING OFF-GAS FLOWS | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-23 | — | — | EP | claimed |
| EP-1250305-A2 | WASTE WATER TREATMENT IN A METHOD FOR PRODUCING FORMIC ACID WHICH IS FREE OF WATER | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-23 | — | — | EP | claimed |
| EP-1250307-A1 | UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-23 | — | — | EP | claimed |
| WO-2001055069-A2 | WASTE WATER TREATMENT IN A METHOD FOR PRODUCING FORMIC ACID WHICH IS FREE OF WATER | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-02 | — | — | WO | claimed |
| WO-2001055071-A1 | UTILIZATION OF AN EXTRACTING AGENT AS ANTIFOAMING AGENT IN THE PRODUCTION OF ANHYDROUS FORMIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-02 | — | — | WO | claimed |
| WO-2001055070-A2 | METHOD FOR CLEANING OFF-GAS FLOWS | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-02 | — | — | WO | claimed |
| WO-2001055077-A2 | FACILITY AND METHOD FOR THE PRODUCTION OF ANHYDROUS FORMIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009057-A1 | Utilization of an extracting agent as antifoaming agent in the production of anhydrous formic acid | F2, ACSL3, ACSL1 | ADH1B 1131/4885ADH1C 196/4885ADH1A 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.